Fledgling pharmaceutical stock set to grow

ALLTRACEL Pharmaceuticals, the Dublin-based manufacturer of anti-bleeding and wound-care products, will continue its strong share price momentum, according to research published last week by Davy stockbrokers.

The company, which listed on London’s Alternative Investment Market (AIM) in 2001, has seen its share price rise from 14p at the start of the year to its current level of 44p.

It now enjoys a market capitalisation of over £30m (€44m) but is still some way off its listing price of 89p.